Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer*
暂无分享,去创建一个
Allan B. Okey | Frank J. Gonzalez | D. Nebert | F. Gonzalez | A. Okey | T. Dalton | Daniel W. Nebert | Timothy P. Dalton
[1] M. Denison,et al. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. , 2003, Annual review of pharmacology and toxicology.
[2] K. Xue,et al. Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. , 2001, Mutation research.
[3] D. Nebert,et al. Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery. , 2000, Biochemical and biophysical research communications.
[4] D W Nebert,et al. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. , 1996, DNA and cell biology.
[5] F. Gonzalez. Role of Gene Knockout and Transgenic Mice in the Study of Xenobiotic Metabolism , 2003, Drug metabolism reviews.
[6] R S McCuskey,et al. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] B. Morris,et al. Association of Ile462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[8] F. Guengerich,et al. Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. , 1996, Cancer research.
[9] D. Russell,et al. Clinical importance of the cytochromes P450 , 2002, The Lancet.
[10] D. Nebert,et al. Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. Distinction between the "responsive" homozygote and heterozygote at the Ah locus. , 1975, Archives of Biochemistry and Biophysics.
[11] D. Nebert,et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. , 1991, American journal of human genetics.
[12] D. Nebert,et al. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. , 1968, The Journal of biological chemistry.
[13] D. Nebert,et al. Decrease in 4-aminobiphenyl-induced methemoglobinemia in Cyp1a2(-/-) knockout mice. , 2002, Toxicology and applied pharmacology.
[14] K. Noda,et al. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. , 1995, Carcinogenesis.
[15] W. Tan,et al. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. , 2001, Carcinogenesis.
[16] F. Gonzalez,et al. Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. , 2001, Pharmacogenetics.
[17] P. Grover,et al. Enzyme-catalysed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. , 1968, The Biochemical journal.
[18] D. Nebert,et al. The in vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. , 1969, Archives of biochemistry and biophysics.
[19] M. Ingelman-Sundberg,et al. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. , 1997, Biochemical and biophysical research communications.
[20] N P Wray,et al. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. , 1982, Cancer research.
[21] D. Nebert,et al. Mitochondrial reactive oxygen production is dependent on the aromatic hydrocarbon receptor. , 2002, Free radical biology & medicine.
[22] Y. Fujii‐Kuriyama,et al. Aryl hydrocarbon receptor mediates benzene-induced hematotoxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[23] Mario Medvedovic,et al. 4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice. , 2003, Journal of the National Cancer Institute.
[24] J M Ward,et al. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. , 1996, Toxicology and applied pharmacology.
[25] C. Jefcoate,et al. Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver. , 2003, Toxicology and applied pharmacology.
[26] T. Pineau,et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor , 1995, Science.
[27] D W Nebert,et al. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. , 1989, Critical reviews in toxicology.
[28] S. Orrenius,et al. Cytochrome P-450 in human fetal liver microsomes. , 1971, Chemico-biological interactions.
[29] T. Pineau,et al. Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2. , 1996, Pharmacogenetics.
[30] J. Smart,et al. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. , 2000, Pharmacogenetics.
[31] J. Ward,et al. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. E. Hahn,et al. Aryl hydrocarbon receptors: diversity and evolution. , 2002, Chemico-biological interactions.
[33] A. Luch,et al. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation. , 2002, Chemical research in toxicology.
[34] E. Snyderwine,et al. Effect of CYP1A2 deficiency on heterocyclic amine DNA adduct levels in mice. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[35] F. Curriero,et al. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. , 2004, Toxicology and applied pharmacology.
[36] A. Conney. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture. , 2003, Cancer research.
[37] D. Nebert,et al. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. , 2000, Biochemical pharmacology.
[38] J. Ward,et al. CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice. , 1999, Carcinogenesis.
[39] C R Shaw,et al. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. , 1973, The New England journal of medicine.
[40] E. Jabs,et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. , 1994, The Journal of biological chemistry.
[41] T. Shimada,et al. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. , 2002, Carcinogenesis.
[42] D. Rank,et al. Sequence variation and phylogenetic history of the mouse Ahr gene. , 2002, Pharmacogenetics.
[43] D W Nebert,et al. Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Nebert,et al. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. , 2004, Molecular pharmacology.
[45] T. Page,et al. 7,12-Dimethylbenz[a]anthracene-induced bone marrow toxicity is p53-dependent. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[46] K. Kawajiri,et al. High Susceptibility to Lung Cancer Analyzed in Terms of Combined Genotypes of P450IA1 and Mu‐class Glutathione S‐Transferase Genes , 1992, Japanese journal of cancer research : Gann.
[47] E. Glover,et al. Tumour promotion by TCDD in skin of HRS/J hairless mice , 1982, Nature.
[48] P. Harper,et al. Polymorphisms in the human AH receptor. , 2002, Chemico-biological interactions.
[49] J. Ward,et al. Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. , 2003, Carcinogenesis.
[50] O. Hankinson. The aryl hydrocarbon receptor complex. , 1995, Annual review of pharmacology and toxicology.
[51] L. Wattenberg,et al. Benzpyrene hydroxylase activity in the gastrointestinal tract. , 1962, Cancer research.
[52] C. Tohyama,et al. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[53] K. Tanaka,et al. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. , 1998, Pharmacogenetics.
[54] F. Guengerich. Metabolism of chemical carcinogens. , 2000, Carcinogenesis.
[55] Y. Fujii‐Kuriyama,et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[56] G. Kellermann,et al. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. , 1973, American journal of human genetics.